Background: Extended, more effective breast cancer (BC) treatments have increased the prevalence of long term survivors. We investigated the risk of latePedersen, Rikke NoergaardEsen, Buket .Mellemkjr, LeneChristiansen, PeerEjlertsen, Bent
The current validation study on tumor samples from the TEAM trial aimed to assess the ability of CAB to predict the risk of distant recurrence at ten years for the first time, for postmenopausal patients with early breast cancer, HR-positive, HER2-negative, node-negative or positive disease....
They found that their algorithm was able to successfully predict recurrence-free survival after 10 years. To validate their findings, the group compared their results to an independent sample of 163 patients withbreast cancerfrom the publicly available Cancer Imaging Archive. While imaging may not com...
Objectives Endometrial cancer is the sixth most common cancer among women and recurrence of after 10 years is extremely rare. Case presentation We reported a comprehensive review of histopathology, investigations and treatment regarding a woman with dist
Postmenopausal women with early breast cancer showed a reduction in disease recurrence after 10 years of aromatase inhibitor therapy with letrozole. The phase 3 clinical trial MA.17R found that postmenopausal women with early breast cancer had a reduction in disease recurrence after 10 years of hormon...
BACKGROUND: All women with early breast cancer, even those with small tumors and negative nodes, remain at appreciable risk of recurrence after surgery over the subsequent 10-15 years. In women with tumors expressing estrogen receptors and/or progesterone receptors, standard systemic adjuvant therapy...
Evaluation of factors related to late recurrence--later than 10 years after the initial treatment--in primary breast cancer. Background: Breast cancer is associated with a relatively good prognosis. Prognostic factors examined to date are related to early recurrence while those r... R Nishimura,T...
Are PROMs sufficient to record late outcome of breast cancer patients treated with radiotherapy? A comparison between patient and clinician reported outcome through an outpatient clinic after 10years of follow up. Radiother Oncol. 2018;126(1):163–9. https://doi.org/10.1016/j.radonc.2017.08.004...
Occasionally, breast cancer relapses more than 5 years after initial treatment, sometimes with highly aggressive disease in such late-recurring patients. This study investigated predictors of recurrence after more than 5 years in operable breas
Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10 years in early stage breast cancer: Tanis E, van de Velde CJH, Bartelink H, et al (The Netherlands Cancer Inst, Amsterdam; Leiden Univ Med Centre, The Netherla...